BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36882396)

  • 1. ACSL1-induced ferroptosis and platinum resistance in ovarian cancer by increasing FSP1 N-myristylation and stability.
    Zhang Q; Li N; Deng L; Jiang X; Zhang Y; Lee LTO; Zhang H
    Cell Death Discov; 2023 Mar; 9(1):83. PubMed ID: 36882396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRMT1 inhibition promotes ferroptosis sensitivity via ACSL1 upregulation in acute myeloid leukemia.
    Zhou L; Jia X; Shang Y; Sun Y; Liu Z; Liu J; Jiang W; Deng S; Yao Q; Chen J; Li H
    Mol Carcinog; 2023 Aug; 62(8):1119-1135. PubMed ID: 37144835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis.
    Bersuker K; Hendricks JM; Li Z; Magtanong L; Ford B; Tang PH; Roberts MA; Tong B; Maimone TJ; Zoncu R; Bassik MC; Nomura DK; Dixon SJ; Olzmann JA
    Nature; 2019 Nov; 575(7784):688-692. PubMed ID: 31634900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of FSP1 myristoylation by NADPH: A novel mechanism for ferroptosis inhibition.
    Liu N; Wu WL; Wan XR; Wang J; Huang JN; Jiang YY; Sheng YC; Wu JC; Liang ZQ; Qin ZH; Wang Y
    Redox Biol; 2024 Jul; 73():103176. PubMed ID: 38705094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCD1/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells.
    Xuan Y; Wang H; Yung MM; Chen F; Chan WS; Chan YS; Tsui SK; Ngan HY; Chan KK; Chan DW
    Theranostics; 2022; 12(7):3534-3552. PubMed ID: 35547771
    [No Abstract]   [Full Text] [Related]  

  • 6. ACSL1-Mediated Fatty Acid β-Oxidation Enhances Metastasis and Proliferation in Endometrial Cancer.
    Zhou Y; Li Y; Chen G; Guo X; Gao X; Meng J; Xu Y; Zhou N; Zhang B; Zhou X
    Front Biosci (Landmark Ed); 2024 Feb; 29(2):66. PubMed ID: 38420815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA.
    Zheng X; Wang Q; Zhou Y; Zhang D; Geng Y; Hu W; Wu C; Shi Y; Jiang J
    Cancer Commun (Lond); 2022 Dec; 42(12):1347-1366. PubMed ID: 36209353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma-activated medium induces ferroptosis by depleting FSP1 in human lung cancer cells.
    Jo A; Bae JH; Yoon YJ; Chung TH; Lee EW; Kim YH; Joh HM; Chung JW
    Cell Death Dis; 2022 Mar; 13(3):212. PubMed ID: 35256587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase separation of FSP1 promotes ferroptosis.
    Nakamura T; Hipp C; Santos Dias Mourão A; Borggräfe J; Aldrovandi M; Henkelmann B; Wanninger J; Mishima E; Lytton E; Emler D; Proneth B; Sattler M; Conrad M
    Nature; 2023 Jul; 619(7969):371-377. PubMed ID: 37380771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic reprogramming of ovarian cancer involves ACSL1-mediated metastasis stimulation through upregulated protein myristoylation.
    Zhang Q; Zhou W; Yu S; Ju Y; To SKY; Wong AST; Jiao Y; Poon TCW; Tam KY; Lee LTO
    Oncogene; 2021 Jan; 40(1):97-111. PubMed ID: 33082557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA.
    Cui M; Wang Y; Sun B; Xiao Z; Ye L; Zhang X
    Biochem Biophys Res Commun; 2014 Feb; 444(2):270-5. PubMed ID: 24462768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute lymphoblastic leukemia necessitates GSH-dependent ferroptosis defenses to overcome FSP1-epigenetic silencing.
    Pontel LB; Bueno-Costa A; Morellato AE; Carvalho Santos J; Roué G; Esteller M
    Redox Biol; 2022 Sep; 55():102408. PubMed ID: 35944469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis.
    Hendricks JM; Doubravsky CE; Wehri E; Li Z; Roberts MA; Deol KK; Lange M; Lasheras-Otero I; Momper JD; Dixon SJ; Bersuker K; Schaletzky J; Olzmann JA
    Cell Chem Biol; 2023 Sep; 30(9):1090-1103.e7. PubMed ID: 37178691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FSP1-mediated ferroptosis in cancer: from mechanisms to therapeutic applications.
    Gao R; Wang J; Huang J; Wang T; Guo L; Liu W; Guan J; Liang D; Meng Q; Pan H
    Apoptosis; 2024 Apr; ():. PubMed ID: 38615304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIM21-Promoted FSP1 Plasma Membrane Translocation Confers Ferroptosis Resistance in Human Cancers.
    Gong J; Liu Y; Wang W; He R; Xia Q; Chen L; Zhao C; Gao Y; Shi Y; Bai Y; Liao Y; Zhang Q; Zhu F; Wang M; Li X; Qin R
    Adv Sci (Weinh); 2023 Oct; 10(29):e2302318. PubMed ID: 37587773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YTHDC1 as a tumor progression suppressor through modulating FSP1-dependent ferroptosis suppression in lung cancer.
    Yuan S; Xi S; Weng H; Guo MM; Zhang JH; Yu ZP; Zhang H; Yu Z; Xing Z; Liu MY; Ming DJ; Sah RK; Zhou Y; Li G; Zeng T; Hong X; Li Y; Zeng XT; Hu H
    Cell Death Differ; 2023 Dec; 30(12):2477-2490. PubMed ID: 37903990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediation of Ferroptosis Suppressor Protein 1 Expression via 4-Hydroxy-2-Nonenal Accumulation Contributes to Acquisition of Resistance to Apoptosis and Ferroptosis in Diffuse Large B-Cell Lymphoma.
    Kawade G; Kurata M; Matsuki Y; Fukuda S; Onishi I; Kinowaki Y; Watabe S; Ishibashi S; Ikeda M; Yamamoto M; Ohashi K; Kitagawa M; Yamamoto K
    Lab Invest; 2024 Apr; 104(4):102027. PubMed ID: 38311062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Rewiring toward Oxidative Phosphorylation Disrupts Intrinsic Resistance to Ferroptosis of the Colon Adenocarcinoma Cells.
    Gotorbe C; Durivault J; Meira W; Cassim S; Ždralević M; Pouysségur J; Vučetić M
    Antioxidants (Basel); 2022 Dec; 11(12):. PubMed ID: 36552620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD36 promotes tubular ferroptosis by regulating the ubiquitination of FSP1 in acute kidney injury.
    Ma Y; Huang L; Zhang Z; Yang P; Chen Q; Zeng X; Tan F; Wang C; Ruan X; Liao X
    Genes Dis; 2024 Jan; 11(1):449-463. PubMed ID: 37588197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective fatty acid oxidation in mice with muscle-specific acyl-CoA synthetase 1 deficiency increases amino acid use and impairs muscle function.
    Zhao L; Pascual F; Bacudio L; Suchanek AL; Young PA; Li LO; Martin SA; Camporez JP; Perry RJ; Shulman GI; Klett EL; Coleman RA
    J Biol Chem; 2019 May; 294(22):8819-8833. PubMed ID: 30975900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.